Peptide library › Growth hormone axis
Pegvisomant
Also known as Somavert
Blocks growth hormone's effects; used for acromegaly, a condition caused by too much growth hormone.
What people use it for
- Acromegaly when surgery or other treatments haven't worked
What Pegvisomant does in the body
A modified growth hormone that sticks to the growth hormone receptor without switching it on, so the body's own growth hormone can't act. This brings IGF-1 levels down.
Strength of evidence
Strong: normalises IGF-1 in most people with acromegaly in trials and long-term studies.
Look up the evidence
- Reviews on PubMed: Summaries of the published research
- Clinical trials on PubMed: Published studies in people
- ClinicalTrials.gov: Registered trials, past and ongoing
- Prescribing information (DailyMed, US): Official US label
- Patient leaflets (emc, UK): Official UK product information
Live searches of official databases. New to the terms? See the glossary.
Reported side effects & risks
- Raised liver enzymes, so liver tests are monitored
- Injection-site reactions
- Flu-like symptoms
Who should avoid it or take extra care
- Anyone without acromegaly
- Existing liver problems need close monitoring
Not a complete list. Check with a doctor or pharmacist about your own health and medicines.
Regulatory status
FDA-approved in 2003. Prescription only.
How it's taken
Route: Injection under the skin, daily
How long it lasts (half-life): About 6 days
Latest research & news
- A patient-clinician call for global harmonization of access to second-line medical therapies for acromegaly in the era of personalized medicine
Research · Review · PubMed · Pituitary · 18 Nov 2026 - Novel AIP variant in aggressive somatotroph adenoma presenting as gigantism
Research · Case report · PubMed · JCEM Case Rep · 17 Nov 2026
Picked automatically from PubMed, ClinicalTrials.gov and the FDA, and updated daily. Early, lab and animal studies often don't carry over to people.
Keep track of Pegvisomant privately
Fiala is a free app for logging doses, tracking vials and setting reminders. No account, and everything you log stays on your phone.
Open Pegvisomant in Fiala How to installMore in Growth hormone axis
- TesamorelinGHRH analog approved to reduce excess abdominal fat in people with HIV-associated lipodystrophy.
- SermorelinShort GHRH fragment that stimulates natural growth hormone release.
- CJC-1295Long-acting GHRH analog, often paired with ipamorelin in popular protocols.
- IpamorelinSelective growth hormone secretagogue (ghrelin-receptor agonist).
- HexarelinPotent synthetic growth hormone secretagogue related to GHRP-6.
- GHRP-2Synthetic growth hormone–releasing peptide used in Japan as a diagnostic test.
- GHRP-6First-generation growth hormone–releasing hexapeptide known for strong hunger effects.
- IGF-1 LR3Modified, longer-acting form of insulin-like growth factor 1.
- IGF-1 DESShortened, fast-acting form of insulin-like growth factor 1 sold as a research chemical.
- MK-677Oral growth hormone secretagogue. It is not a peptide, but is commonly tracked alongside them.
- Fragment 176-191Small piece of the growth hormone molecule sold online for fat loss; evidence is from animals only.
- SomatropinLab-made human growth hormone, identical to the body's own, used for growth hormone deficiency and some growth disorders.
- SomapacitanOnce-weekly growth hormone treatment for children and adults with growth hormone deficiency.
- MecaserminLab-made IGF-1 for children who can't grow normally because their bodies don't make enough IGF-1.